Patients with Type 1 and 2 diabetes self-administering or prescribed a specific dietary supplements for wound care.

Intervention (Observed):

Type: Dietary Supplements Name: Diabetic Foot Ulcer Nutritional Protocol

Intervention Type: Dietary Supplement Intervention Name: Diabetic Foot Ulcer Nutritional Protocol

Description:

A specific regimen of daily dietary supplements designed to support metabolic health and accelerated tissue repair in diabetic patients.

The protocol involves the administration of targeted nutrients known to enhance collagen synthesis, reduce systemic inflammation.Participants consume the supplements orally on a daily basis over a 6-week period.

The observation focuses on the supplement's ability to facilitate complete wound closure (epithelialization) and salvage limbs in patients previously scheduled for amputation.

Study Status: Completed (s

Measure Description: Percentage of participants achieving full epithelialization of the target ulcer, defined as the absence of drainage and no further requirement for clinical dressing.

Outcome Measure Title: Rate of Complete Wound Closure Measure Description: Percentage of participants achieving full epithelialization of the target ulcer, defined as the absence of drainage and no further requirement for clinical dressing.

Time Frame: 6 weeks. Outcome Measure Title: Incidence of Lower Extremity Amputation Measure Description: Number of participants requiring minor (toe/transmetatarsal) or major (above/below-knee) amputations during the observation period.

Time Frame: Up to 6 weeks. Outcome Measure Title: Time to Complete Wound Closure Measure Description: Number of weeks required to reach full clinical healing (100% epithelialization) for participants achieving closure.

Time Frame: Weekly for up to 6 weeks. Outcome Measure Title: Change in Wound Surface Area Measure Description: Measurement of the variation in the ulcer's physical dimensions (length x width in millimeters) from baseline to the final assessment.

Outcome Measure Title: Time to Complete Wound Closure Measure Description: Number of weeks required to reach full clinical healing (100% epithelialization) for participants achieving closure.

Time Frame: Weekly for up to 6 weeks. Outcome Measure Title: Change in Wound Surface Area Measure Description: Measurement of the variation in the ulcer's physical dimensions (length x width in millimeters) from baseline to the final assessment.

Outcome Measure Title: Change in Qualitative Tissue Granulation Measure Description: Clinical observation of the transition in tissue type (from necrotic or stagnant to healthy granulation tissue), assessed via weekly clinical evaluation and standardized photographic evidence.

This observational study monitors a cohort of 35 participants with Type 1 or Type 2 Diabetes Mellitus presenting with chronic Wagner Stage 1 to 5 foot ulcers. The study observes the clinical progression of patients who self-administer a specialized dietary supplement protocol. Primary data points include the variation in wound surface area and the clinical incidence of lower extremity amputations within a 6-week observation window.